Price movement over the last 24 hours
Aehr Test Systems vs Bio-Rad Laboratories, Inc. Class A Common Stock — how do they compare? Aehr Test Systems trades at $68.03 (market cap $2.11B), while Bio-Rad Laboratories, Inc. Class A Common Stock trades at $283.5 (market cap $7.85B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 3.7× Aehr Test Systems's market cap, and Aehr Test Systems is trading nearer its 52-week high, Bio-Rad Laboratories, Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals.
| AEHR | BIO | |
|---|---|---|
Market Cap | $2.11B | $7.85B |
Sector | Technology | Health |
52-Week High | $116.58 | $339.75 |
52-Week Low | $13.29 | $241.71 |
Enterprise Value | $2.08B | $7.66B |
Trailing returns across standard periods
Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.
Read more on AEHR →Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →